Company: PGEN
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001356090-25-000024
Chunk: 15

Company: PRECIGEN, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 15
---
Interest income696 319 1,614 927 Other (expense) income, net(31)43 (24)80 Total other (expense) income, net5,125 360 (26,432)1,003 Loss before income taxes(26,639)(60,481)(80,792)(84,248)Income tax (expense) benefit(3)1,689 (3)1,718 Net loss$(26,642)$(58,792)$(80,795)$(82,530)Net loss per shareNet loss per share, basic and diluted$(0.09)$(0.23)$(0.27)$(0.33)Weighted average shares outstanding, basic and diluted296,434,726 252,366,533 295,164,303 250,803,790 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Precigen, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Loss

(Unaudited) 

 Three Months Ended  June 30,Six Months Ended  June 30,(Amounts in thousands)2025202420252024Net loss$(26,642)$(58,792)$(80,795)$(82,530)Other comprehensive loss:Unrealized (loss) gain on investments(1)16 (1)15 Loss on foreign currency translation adjustments— (128)— (977)Comprehensive loss $(26,643)$(58,904)$(80,796)$(83,492)

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

Precigen, Inc. and Subsidiaries

Condensed Consolidated Statements of Mezzanine Equity and Shareholders' Equity (Deficit)

(Unaudited) Mezzanine EquityShareholders' Equity (Deficit)(Amounts in thousands, except share data)Preferred StockCommon StockAdditionalPaid-inCapitalAccumulatedOtherComprehensiveIncome (Loss)AccumulatedDeficitTotalShareholders'Equity (Deficit)SharesAmountSharesAmountBalances at March 31, 202579,000 $29,518 295,135,060 $— $2,130,787 $12 $(2,144,859)$(14,060)Stock-based compensation expense— — — — 1,638 —